HLA-DP-associated susceptibility to the optico-spinal form of multiple sclerosis in the Japanese

Tissue Antigens

Volumn 52, Issue 2, 1998, Pages 179-182

  Ito, H ^a,b   Yamasaki, K ^c   Kawano, Y ^c   Horiuchi, I ^c   Yun, C ^a,d   Nishimura, Y ^a   Kira, J ^c  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d NAGASAKI UNIVERSITY   (Japan)

Author keywords

Disease susceptibility; HLA DP; Japanese population; Multiple sclerosis

Indexed keywords

DNA; HLA DP ANTIGEN;

ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; EYE DISEASE; GENE FREQUENCY; HUMAN; IMMUNOGENETICS; JAPAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; MYELITIS; PRIORITY JOURNAL;

EID: 0031829076     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1998.tb02282.x     Document Type: Article

References (17)

1. Todd JA, Acha-Orbea H, Bell JI et al. A molecular basis for MHC class II-associated autoimmunity. Science 1988: 240: 1003-9.
2. Martin R, McFarland HF, McFarlin DE. Immunological aspects of demyelinating disease. Annu Rev Immunol 1992: 10: 153-87.
3. Shibasaki H, McDonald WI, Kuroiwa Y. Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients. J Neurol Sci 1981: 49: 253-71.
4. Kira J, Kanai T, Nishimura Y et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 1996: 40: 569-74.
5. Olerup O, Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 1991: 38: 1-15.
6. Spurkland A, Ronningen KS, Vandvik B, Thorsby E, Vartdal F. HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclrosis. Hum Immunol 1991: 30: 69-75.
7. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983: 133: 227-31.
8. Kimura A, Sasazuki T. 11th International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991: Proceedings of the 11th International Histocompatibility Workshop and Conference. Vol 1. Oxford: Oxford University Press, 1992: 397-419.
9. Bodmer JG, Marsh SGE, Albert ED et al. Nomenclature for factors of the HLA system, 1996-updates January/February, March, April 1997. In: Charron D, ed. Genetic diversity of HLA, functional and medical implication, Proceedings of the Twelfth International Histcompatibility Workshop and Conference. Vol 1. Paris: Medical and Science International Publishers, 1997: 505-32.
10. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991: Proceedings of the 11th International Histocompatibility Workshop and Conference. Vol. 1. Oxford: Oxford University Press, 1992: 1065-220.
11. Odum N, Saida T, Ohta M, Svejgaard A. HLA-DP antigens and HTLV-1 antibody status among Japanese with multiple screlosis: evidence for an increased frequency of HLA-DPw4. J Immunogenet 1989: 16: 467-73.
12. Begovich AB, Helmuth RC, Oksenberg JR et al. HLA-DPB and susceptibility to multiple sclerosis: an analysis of Caucasoid and Japanese patient populations. Hum Immunol 1990: 28: 365-72.
13. Spurkland A, Tabira T, Ronningen KS, Vandvik B, Thorsby K, Vartdal F. HLA-DRB1, -DQA1, DQB1, -DPA1 and -DPB1 genes in Japanese multiple sclerosis patients. Tissue Antigens 1991: 37: 171-3.
14. Hao Q, Saida T, Kawakami H et al. HLAs and genes in Japanese patients with multiple sclerosis: evidence for increased frequencies of HLA-Cw3, HLA-DR2, and HLA-DQB1*0602. Hum Immunol 1992: 35: 116-24.
15. Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Halfer DA. T-cell recognition of an immunodominant myelin basic-protein epitope in multiple sclerosis. Nature 1990: 346: 183-7.
16. Ohashi T, Yamamura T, Inobe J, Kondo T, Kunishita T, Tabira T. Analysis of proteolipid protein (PLP)-specific T cells in multiple sclerosis: identification of PLP 95-116 as an HLA-DR2, w15-associated determinant. Int Immunol 1995: 7: 1771-8.
17. Kira J, Goto I. Recurrent opticomyelitis associated with anti-DNA antibody. J Neurol Neurosurg Psychiatry 1994: 57: 1124-5.